Differentiating Seborrheic Dermatitis: Immunologic and Clinical Insight

In this episode, Differentiating Seborrheic Dermatitis: Immunologic and Clinical Insights, the dermatologists explore the following questions:

How do you distinguish SD from other chronic inflammatory dermatoses, such as atopic dermatitis and psoriasis?

What are the specific immune and barrier dysfunction pathways that are implicated in SD?

What are the clinical implications of (Th)17/Th22 cytokine involvement in SD, particularly in identifying potential therapeutic targets for SD treatment selection?

The panelists examined how to distinguish seborrheic dermatitis (SD) from other chronic inflammatory dermatoses such as atopic dermatitis and psoriasis requires careful assessment of lesion distribution, morphology, symptom profile, and disease chronicity. SD typically presents with erythematous, greasy scale in seborrheic areas, whereas atopic dermatitis is more pruritic and flexural, and psoriasis features well-demarcated plaques with thicker scale. At the molecular level, SD is associated with a distinct pattern of immune activation and epidermal barrier dysfunction that differs from classic Th2-driven atopic disease and Th1/Th17-dominant psoriasis. Emerging evidence highlights the role of Th17 and Th22 cytokine pathways in driving inflammation, keratinocyte activation, and barrier disruption in SD. These pathways contribute to persistent inflammation and may help explain overlap features seen in some patients. Understanding Th17/Th22 involvement has important clinical implications, as it supports the rationale for targeted, non-steroidal therapies that modulate specific inflammatory pathways. This evolving immunologic framework can help guide more precise diagnosis and treatment selection for patients with SD.

Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

The next episode in this series, Age-Specific Presentation and Quality-of-Life Impact of Seborrheic Dermatitis, features the panelists advancing their conversation and focusing on how the clinical presentation of seborrheic dermatitis differs across infants, adolescents, and adults, highlighting age-related patterns in distribution and severity. It also explores key disease factors—including pruritus, lesion visibility, and psychosocial burden—that significantly influence quality of life for patients with SD.